HH
TNDM icon

Hilltop Holdings’s Tandem Diabetes Care TNDM Stock Holding History

Hilltop Holdings’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,605
Closed -$229K – 417
2019
Q1 		$229K Buy
+3,605
New +$189K 0.05% 337

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Hilltop Holdings's TNDM Position: Q2 2019 in Review

Hilltop Holdings sold out of Tandem Diabetes Care (TNDM) in Q2 2019, closing a stake of 3,605 shares — an estimated $229K sold.

Hilltop Holdings first reported a position in TNDM in Q1 2019 and held it in 1 quarter. The position peaked at $229K in Q1 2019. 261 funds tracked by Wall St. Rank hold TNDM as of Q2 2019.

  • Hilltop Holdings reported no remaining Tandem Diabetes Care position as of Q2 2019 after selling out during the quarter.
  • Hilltop Holdings sold 3,605 Tandem Diabetes Care shares in Q2 2019, an estimated $229K.
  • Hilltop Holdings first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 1 quarter.
  • Hilltop Holdings's Tandem Diabetes Care position peaked at $229K in Q1 2019.
  • 261 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2019.

Based on Hilltop Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.